Viewing Study NCT00053157


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-01-02 @ 10:08 AM
Study NCT ID: NCT00053157
Status: COMPLETED
Last Update Posted: 2022-10-05
First Post: 2003-01-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
Sponsor: Roswell Park Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module